Aurin Biotech's Unattributed Round

Aurin Biotech raised a round of funding on December 19, 2013.

Aurin Biotech is a private corporation established to develop clinical applications of agents that can block self attack by aberrant complement activation. Such attack has been reported to occur in ma…

Articles about Aurin Biotech's Unattributed Round: